Search research articles
Contact Us
Filters
Showing results (1-10 of 38) with videos related to
Page
of 4
Sort By:
International Journal of Rheumatic Diseases
|
October 9, 2025
The PROMIS-29 and SF-36 Quality of Life Scales Are Not Interchangeable in Systemic Sclerosis
Murray Baron, Charmaine van Eeden, Mohamed Osman, et al.
Arthritis Research & Therapy
|
June 7, 2020
Immunosuppressive treatment in diffuse cutaneous systemic sclerosis is associated with an improved composite response index (CRISS)
Boyang Zheng, Marie Hudson, Mianbo Wang, et al.
Journal of Scleroderma and Related Disorders
|
June 8, 2023
Occupation as a gendered-role and outcome in systemic sclerosis
Fatema Alkhamees, Oriana Hoi Yun Yu, Mianbo Wang, et al.
Journal of Scleroderma and Related Disorders
|
April 6, 2022
Interstitial lung disease is associated with an increased risk of lung cancer in systemic sclerosis: Longitudinal data from the Canadian Scleroderma Research Group
Lama Sakr, Marie Hudson, Mianbo Wang, et al.
Journal of Scleroderma and Related Disorders
|
April 7, 2022
NT-proBNP, hs-cTnT, and CRP predict the risk of cardiopulmonary outcomes in systemic sclerosis: Findings from the Canadian Scleroderma Research Group
Mayank Jha, Mianbo Wang, Russell Steele, et al.
Seminars in Arthritis and Rheumatism
|
May 12, 2015
Thinking outside the box--The associations with cutaneous involvement and autoantibody status in systemic sclerosis are not always what we expect
Neha Srivastava, Marie Hudson, Solène Tatibouet, et al.
Rheumatology (Oxford, England)
|
October 2, 2021
Association between autoantibodies in systemic sclerosis and cancer in a national registry
Sabrina Hoa, Selma Lazizi, Murray Baron, et al.
Seminars in Arthritis and Rheumatism
|
February 12, 2022
Associations between the Composite Response Index in Diffuse Cutaneous Systemic Sclerosis (CRISS), survival and other disease measures
Boyang Zheng, Mianbo Wang, Wendy Stevens, et al.
Journal of Scleroderma and Related Disorders
|
March 31, 2025
The minimal clinically important difference of the scleroderma clinical trials consortium damage index
Murray Baron, Dylan Hansen, Susanna Proudman, et al.
Arthritis Care & Research
|
November 14, 2024
Immunosuppressive Drugs in Early Systemic Sclerosis and Prevention of Damage Accrual
Murray Baron, Mandana Nikpour, Dylan Hansen, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 38) with videos related to
Sort By:
Page
of 4
International Journal of Rheumatic Diseases
|
October 9, 2025
The PROMIS-29 and SF-36 Quality of Life Scales Are Not Interchangeable in Systemic Sclerosis
Murray Baron, Charmaine van Eeden, Mohamed Osman, et al.
Arthritis Research & Therapy
|
June 7, 2020
Immunosuppressive treatment in diffuse cutaneous systemic sclerosis is associated with an improved composite response index (CRISS)
Boyang Zheng, Marie Hudson, Mianbo Wang, et al.
Journal of Scleroderma and Related Disorders
|
June 8, 2023
Occupation as a gendered-role and outcome in systemic sclerosis
Fatema Alkhamees, Oriana Hoi Yun Yu, Mianbo Wang, et al.
Journal of Scleroderma and Related Disorders
|
April 6, 2022
Interstitial lung disease is associated with an increased risk of lung cancer in systemic sclerosis: Longitudinal data from the Canadian Scleroderma Research Group
Lama Sakr, Marie Hudson, Mianbo Wang, et al.
Journal of Scleroderma and Related Disorders
|
April 7, 2022
NT-proBNP, hs-cTnT, and CRP predict the risk of cardiopulmonary outcomes in systemic sclerosis: Findings from the Canadian Scleroderma Research Group
Mayank Jha, Mianbo Wang, Russell Steele, et al.
Seminars in Arthritis and Rheumatism
|
May 12, 2015
Thinking outside the box--The associations with cutaneous involvement and autoantibody status in systemic sclerosis are not always what we expect
Neha Srivastava, Marie Hudson, Solène Tatibouet, et al.
Rheumatology (Oxford, England)
|
October 2, 2021
Association between autoantibodies in systemic sclerosis and cancer in a national registry
Sabrina Hoa, Selma Lazizi, Murray Baron, et al.
Seminars in Arthritis and Rheumatism
|
February 12, 2022
Associations between the Composite Response Index in Diffuse Cutaneous Systemic Sclerosis (CRISS), survival and other disease measures
Boyang Zheng, Mianbo Wang, Wendy Stevens, et al.
Journal of Scleroderma and Related Disorders
|
March 31, 2025
The minimal clinically important difference of the scleroderma clinical trials consortium damage index
Murray Baron, Dylan Hansen, Susanna Proudman, et al.
Arthritis Care & Research
|
November 14, 2024
Immunosuppressive Drugs in Early Systemic Sclerosis and Prevention of Damage Accrual
Murray Baron, Mandana Nikpour, Dylan Hansen, et al.
Page
of 4